Guest DaveG Posted November 27, 2003 Share Posted November 27, 2003 I will be participating in a Phase II, Randomized, double blind, 2 Part, Multicenter Study to compare the Efficacy of ZD6474 with the Efficacy of ZD1839 (Iressa). In this study I will receive one of the above drugs plus a placebo on a daily basis. The study will continue for an undisclosed period, or until it is demonstrated that no benefit is being shown. If no benefit is shown, and the tumor continues to grow, the particular study drug I am taking will be removed and I will go into a 4 week withdrawn period. Then I will restart the study with the opposite drug. The exact drug I receive will not be disclosed. I will be starting in the study 12-02-03, with initial tests, CT Scan, baseline ECG, and baseline blood work. On 12-09-03 I will begin taking the drug. It is expected that I will be in the research unit for a period of 8-10 hours after taking the initial dose. Periodic blood samples will be drawn after administration of the initial dose. This is the study in a "nutshell". Hopefully it will work and arrest the growth of the tumor. If this does not work, I will be offered other treatments. Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.